BACKGROUND: Phenotypic switch of vascular smooth muscle cells (VSMCs) accompanies neointima formation and associates with vascular diseases. Platelet-derived growth factor (PDGF)-induced activation of PDGFR/Akt1 and β-catenin signaling pathways in VSMCs has been implicated in vessel occlusion. Transglutaminase 2 (TG2) regulates these pathways and its levels are increased in the neointima. OBJECTIVE: The aim of this study was to evaluate the role of TG2 in PDGF/β-catenin signaling cross-talk and assess its contribution to neointima. METHODS: Aortic VSMCs from wild-type and TG2 knockout mice were tested in vitro for levels of VSMC markers, proliferation, migration and PDGF-induced activation of PDGFR/Akt1 and β-catenin pathways. Neointima in these mice was studied ex vivo in coronary vessels using a heart slice model and in vivo using a carotid artery ligation model. RESULTS: Genetic deletion of TG2 attenuated the PDGF-induced phenotypic switch of aortic VSMCs, reduced their proliferation and migration rates, and inhibited PDGF-induced activation of PDGFR/Akt1 and β-catenin pathways in both ex vivo and in vivo neointima models. Importantly, genetic deletion of TG2 also markedly attenuated vessel occlusion. CONCLUSIONS: TG2 promotes neointima formation by mediating the PDGF-induced activation of the PDGFR/Akt1 and β-catenin pathways in VSMCs. This study identifies TG2 as a potential therapeutic target for blocking neointima in blood vessels.
BACKGROUND: Phenotypic switch of vascular smooth muscle cells (VSMCs) accompanies neointima formation and associates with vascular diseases. Platelet-derived growth factor (PDGF)-induced activation of PDGFR/Akt1 and β-catenin signaling pathways in VSMCs has been implicated in vessel occlusion. Transglutaminase 2 (TG2) regulates these pathways and its levels are increased in the neointima. OBJECTIVE: The aim of this study was to evaluate the role of TG2 in PDGF/β-catenin signaling cross-talk and assess its contribution to neointima. METHODS: Aortic VSMCs from wild-type and TG2 knockout mice were tested in vitro for levels of VSMC markers, proliferation, migration and PDGF-induced activation of PDGFR/Akt1 and β-catenin pathways. Neointima in these mice was studied ex vivo in coronary vessels using a heart slice model and in vivo using a carotid artery ligation model. RESULTS: Genetic deletion of TG2 attenuated the PDGF-induced phenotypic switch of aortic VSMCs, reduced their proliferation and migration rates, and inhibited PDGF-induced activation of PDGFR/Akt1 and β-catenin pathways in both ex vivo and in vivo neointima models. Importantly, genetic deletion of TG2 also markedly attenuated vessel occlusion. CONCLUSIONS:TG2 promotes neointima formation by mediating the PDGF-induced activation of the PDGFR/Akt1 and β-catenin pathways in VSMCs. This study identifies TG2 as a potential therapeutic target for blocking neointima in blood vessels.
Authors: Thomas R DiRaimondo; Cornelius Klöck; Rod Warburton; Zachary Herrera; Krishna Penumatsa; Deniz Toksoz; Nicholas Hill; Chaitan Khosla; Barry Fanburg Journal: ACS Chem Biol Date: 2013-11-05 Impact factor: 5.100
Authors: Lin Wei; Rod R Warburton; Ioana R Preston; Kari E Roberts; Suzy A A Comhair; Serpil C Erzurum; Nicholas S Hill; Barry L Fanburg Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-04-20 Impact factor: 5.464
Authors: Erik N T P Bakker; Carsten L Buus; Jos A E Spaan; Jop Perree; Anuradha Ganga; Titia M Rolf; Oana Sorop; Linda H Bramsen; Michael J Mulvany; Ed Vanbavel Journal: Circ Res Date: 2004-11-18 Impact factor: 17.367
Authors: Sung Mee Jung; Simran Jandu; Jochen Steppan; Alexey Belkin; Steven S An; Alina Pak; Eric Y Choi; Daniel Nyhan; Mark Butlin; Kayla Viegas; Alberto Avolio; Dan E Berkowitz; Lakshmi Santhanam Journal: Am J Physiol Heart Circ Physiol Date: 2013-07-19 Impact factor: 4.733
Authors: Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani Journal: Arterioscler Thromb Vasc Biol Date: 2007-05-17 Impact factor: 8.311
Authors: Jeroen van den Akker; Ed VanBavel; Remon van Geel; Hanke L Matlung; Bilge Guvenc Tuna; George M C Janssen; Peter A van Veelen; Wilbert C Boelens; Jo G R De Mey; Erik N T P Bakker Journal: PLoS One Date: 2011-08-25 Impact factor: 3.240
Authors: Jochen Steppan; Yehudit Bergman; Kayla Viegas; Dinani Armstrong; Siqi Tan; Huilei Wang; Sean Melucci; Daijiro Hori; Sung Yong Park; Sebastian F Barreto; Abraham Isak; Sandeep Jandu; Nicholas Flavahan; Mark Butlin; Steven S An; Alberto Avolio; Dan E Berkowitz; Marc K Halushka; Lakshmi Santhanam Journal: J Am Heart Assoc Date: 2017-02-03 Impact factor: 5.501